Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
myotwin has developed a proprietary platform using stem cell-derived 3D human heart organoids combined with the Trinity Measurement system. This allows comprehensive preclinical testing of cardiac drugs by measuring contractility, electrophysiology, calcium dynamics and tissue stiffness simultaneously. The approach enables animal-free drug development and provides more predictive data on human cardiac responses to new compounds. The company is focused on supporting pharmaceutical R&D with more accurate models to reduce clinical trial failures and promote ethical research practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on myotwin GmbH.